Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Champlin

Showing results (251-260 of 279) with videos related to

Pageof 28
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 28, 1999
Marrow transplantation from unrelated donors for patients with severe aplastic anemia who have failed immunosuppressive therapyH J Deeg, K Seidel, J Casper, et al.
British Journal of Haematology|July 27, 2005
Sirolimus in combination with tacrolimus and corticosteroids for the treatment of resistant chronic graft-versus-host diseaseD R Couriel, R Saliba, M P Escalón, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 30, 2015
Allogeneic stem-cell transplantation in patients with cutaneous lymphoma: updated results from a single institutionC Hosing, R Bassett, B Dabaja, et al.
Blood|December 1, 1996
Tacrolimus and minidose methotrexate for prevention of acute graft-versus-host disease after matched unrelated donor marrow transplantationD Przepiorka, C Ippoliti, I Khouri, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 1, 1997
Allogeneic transplantation for recurrent or refractory non-Hodgkin's lymphoma with poor prognostic features after conditioning with thiotepa, busulfan, and cyclophosphamide: experience in 44 consecutive patientsK van Besien, P Thall, M Korbling, et al.
Bone Marrow Transplantation|January 10, 2006
Superior ex vivo cord blood expansion following co-culture with bone marrow-derived mesenchymal stem cellsS N Robinson, J Ng, T Niu, et al.
Leukemia|February 19, 2010
Identifying candidate allogeneic NK-cell donors for hematopoietic stem-cell transplantation based on functional phenotypeL V Hurton, R I Siddik, H Singh, et al.
Bone Marrow Transplantation|January 23, 2008
Transplantation of ex vivo expanded cord blood cells using the copper chelator tetraethylenepentamine: a phase I/II clinical trialM de Lima, J McMannis, A Gee, et al.
Blood|December 1, 1995
CD8-depleted donor lymphocyte infusion as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantationS Giralt, J Hester, Y Huh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantationR H Collins, O Shpilberg, W R Drobyski, et al.
Pageof 28

Showing results (251-260 of 279) with videos related to

Sort By:
Pageof 28
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 28, 1999
Marrow transplantation from unrelated donors for patients with severe aplastic anemia who have failed immunosuppressive therapyH J Deeg, K Seidel, J Casper, et al.
British Journal of Haematology|July 27, 2005
Sirolimus in combination with tacrolimus and corticosteroids for the treatment of resistant chronic graft-versus-host diseaseD R Couriel, R Saliba, M P Escalón, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 30, 2015
Allogeneic stem-cell transplantation in patients with cutaneous lymphoma: updated results from a single institutionC Hosing, R Bassett, B Dabaja, et al.
Blood|December 1, 1996
Tacrolimus and minidose methotrexate for prevention of acute graft-versus-host disease after matched unrelated donor marrow transplantationD Przepiorka, C Ippoliti, I Khouri, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 1, 1997
Allogeneic transplantation for recurrent or refractory non-Hodgkin's lymphoma with poor prognostic features after conditioning with thiotepa, busulfan, and cyclophosphamide: experience in 44 consecutive patientsK van Besien, P Thall, M Korbling, et al.
Bone Marrow Transplantation|January 10, 2006
Superior ex vivo cord blood expansion following co-culture with bone marrow-derived mesenchymal stem cellsS N Robinson, J Ng, T Niu, et al.
Leukemia|February 19, 2010
Identifying candidate allogeneic NK-cell donors for hematopoietic stem-cell transplantation based on functional phenotypeL V Hurton, R I Siddik, H Singh, et al.
Bone Marrow Transplantation|January 23, 2008
Transplantation of ex vivo expanded cord blood cells using the copper chelator tetraethylenepentamine: a phase I/II clinical trialM de Lima, J McMannis, A Gee, et al.
Blood|December 1, 1995
CD8-depleted donor lymphocyte infusion as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantationS Giralt, J Hester, Y Huh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantationR H Collins, O Shpilberg, W R Drobyski, et al.
Pageof 28